About Sino Medical Sciences Technology Inc. Company

The company is an international company rooted in China, targeting the global market, focusing on R&D, production and sales of high-end interventional medical devices. The company was founded in the Tianjin Economic and Technological Development Zone in 2007. In October 2019, the company landed on the Shanghai Stock Exchange and became a listed company on the Science and Technology Innovation Board. After more than ten years of development, the company has established a world-class R&D, production and operation system, and its business covers key areas of interventional treatment such as cardiovascular, cerebrovascular, and structural heart diseases. The company's main business is R&D, production and sales of cardiac and intracranial Class III interventional medical device products. The company's main products are coronary stents, coronary balloons, neural stents, neural balloons and related products. Corporate honors: Tianjin Science and Technology Progress First Prize, Best Support Award, Sino-French Teamwork Innovation Gold Award, China's 100 Most Growing Entrepreneurial Enterprises for Studying Abroad, etc.